weekly glp 1 agonist Dosage of GLP-1 analogues Glucagon-Like Peptide-1 Receptor Agonist Use

Learn why GLP-1 drugs cannot rebuild metabolism, and how SCFAs & gut bacteria may support lasting balance

If you are taking medications or have a medical condition, speak with your provider before use

Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)

Individuals seeking targeted probiotic strains associated with metabolic pathways

Read highlights from the released 2025 Standards of Care, including recommendations for CGM use in type 2 diabetes for the first time, the use of GLP-1 drugs for kidney and heart benefits and a warning of DKA risk in recreational marijuana use.